+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Evenity"

From
Disease Analysis: Osteoporosis - Product Thumbnail Image

Disease Analysis: Osteoporosis

  • Report
  • March 2021
  • 48 Pages
  • Global
Osteoporosis Market and Forecast Analysis - Product Thumbnail Image

Osteoporosis Market and Forecast Analysis

  • Report
  • January 2019
  • 212 Pages
  • Global
From
Drug Overview: Evenity - Product Thumbnail Image

Drug Overview: Evenity

  • Report
  • March 2018
  • 17 Pages
  • Global
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

The Evenity market is a subset of the Musculoskeletal Disorders Drugs market, which focuses on treatments for conditions such as osteoporosis, rheumatoid arthritis, and ankylosing spondylitis. Evenity is a biologic drug used to treat osteoporosis in postmenopausal women, and is designed to reduce the risk of fractures. It is administered as an intravenous infusion, and is typically used in combination with other treatments. The Evenity market is highly competitive, with a number of companies offering similar treatments. These include Amgen, Eli Lilly, Merck, Novartis, and Pfizer. Each company has its own unique approach to the treatment of musculoskeletal disorders, and offers a range of products and services to meet the needs of patients. Show Less Read more